Androgen receptors, androgen-dependent proliferation, and 5α-reductase activity of small-cell lung cancer cell lines
✍ Scribed by M. Maasberg; M. Rotsch; G. Jaques; U. Enderle-Schmidt; R. Weehle; K. Havemann
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 703 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
We investigated the influence of testosterone on binding to established small-cell lung cancer (SCLC) cell lines and were able to show specific high-affinity and low-capacity binding sites in some cell lines with a typical receptor size, using sucrose density gradient centrifugation. In addition, we demonstrated marked growth stimulation with testosterone and dehydrotestosterone using different androgen-receptor-positive small-cell lung cancer cell lines. This growth stimulation could be counteracted by the addition of anti-androgens like cyproterone acetate or flutamide. The presence of 5a-reductase activity, I 7P-hydroxysteroid-deh ydrogenase and 3a-hydroxysteroid-dehydrogenase activities could be demonstrated, suggesting testosterone metabolism of small-cell lung cancer cell lines.
📜 SIMILAR VOLUMES
## Abstract Androgen and androgen receptor (AR) are involved in growth of normal prostate and development of prostatic diseases including prostate cancer. Androgen deprivation therapy is used for treating advanced prostate cancer. This therapeutic approach focuses on suppressing the accumulation of
## Background: The presence and possible role of androgen-metabolizing enzymes in androgen-independent prostate carcinoma (cap) are still unclear. the aim of the present study was: 1) to evaluate the pattern of androgen metabolism (relative production of 5alpha-reduced vs. 17-keto androgens); and 2